Your browser doesn't support javascript.
loading
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.
Lisenko, Katharina; Sauer, Sandra; Bruckner, Thomas; Egerer, Gerlinde; Goldschmidt, Hartmut; Hillengass, Jens; Schmier, Johann W; Shah, Sofia; Witzens-Harig, Mathias; Ho, Anthony D; Wuchter, Patrick.
Afiliação
  • Lisenko K; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Sauer S; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Bruckner T; Institute of Medical Biometry und Informatics, Heidelberg University, Marsilius Arkaden 130.3, 69120, Heidelberg, Germany.
  • Egerer G; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Goldschmidt H; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Hillengass J; National Center for Tumor Diseases Heidelberg (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Schmier JW; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Shah S; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Witzens-Harig M; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Ho AD; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Wuchter P; Department of Medicine V, Heidelberg University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
BMC Cancer ; 17(1): 151, 2017 02 22.
Article em En | MEDLINE | ID: mdl-28228122

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Alquilantes / Melfalan / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Alquilantes / Melfalan / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha